Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-01-19

FDA Approved: NATEGLINIDE — Supplemental Application (Modavar Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved a supplemental application for nateglinide submitted by Modavar Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nateglinide (nateglinide)

Snippet

SUPPL AP for NATEGLINIDE (NATEGLINIDE)